Singapore markets closed

BioCryst Pharmaceuticals, Inc. (BCRX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
12.60+0.24 (+1.94%)
At close: 04:00PM EDT
12.87 +0.27 (+2.14%)
After hours: 07:30PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
31/12/2018
Total revenue
203,607
157,170
17,812
48,835
20,653
Cost of revenue
1,519
7,264
1,676
4,101
471
Gross profit
202,088
149,906
16,136
44,734
20,182
Operating expenses
Research development
240,850
208,808
122,964
107,068
84,888
Selling general and administrative
142,678
118,818
67,929
37,121
29,514
Total operating expenses
383,528
327,626
190,893
144,189
114,402
Operating income or loss
-181,440
-177,720
-174,757
-99,455
-94,220
Interest expense
80,754
59,294
14,501
11,892
9,176
Total other income/expenses net
55,261
55,143
-2,976
517
-108
Income before tax
-206,247
-181,809
-182,814
-108,897
-101,252
Income tax expense
3,388
2,253
-
-
-
Income from continuing operations
-209,635
-184,062
-182,814
-108,897
-101,252
Net income
-209,635
-184,062
-182,814
-108,897
-101,252
Net income available to common shareholders
-209,635
-184,062
-182,814
-108,897
-101,252
Basic EPS
-
-1.03
-1.09
-0.94
-0.98
Diluted EPS
-
-1.03
-1.09
-0.94
-0.98
Basic average shares
-
179,117
167,267
115,600
103,185
Diluted average shares
-
179,117
167,267
115,600
103,185
EBITDA
-
-121,738
-167,565
-96,281
-91,306